Concepedia

Ron H.J. Mathijssen

RH

Statistics

Publications

253

Citations

14.8K

H-Index

67

Active since

1998

Affiliations

Erasmus MC Cancer Institute(Current)

Erasmus MC

Erasmus University Rotterdam

The Netherlands Cancer Institute

Leiden University Medical Center

Ron H.J. Mathijssen is an author at Erasmus MC Cancer Institute specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

1998–2025

253

Publications

253

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Ron H.J. Mathijssen, R J van Alphen, Jaco J. Verweij et al. · PubMed · 2001 · 752 citations · Full text

, , +17

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Amit M. Oza, David Cibula, Ana Oaknin Benzaquen et al. · The Lancet Oncology · 2014 · 544 citations

, , +14

Effects of St. John's Wort on Irinotecan Metabolism

Ron H.J. Mathijssen · JNCI Journal of the National Cancer Institute · 2002 · 447 citations · Full text

, , +16

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 419 citations · Full text

, , +16

Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity

Kelly K. Filipski, Ron H.J. Mathijssen, Torben Stamm Mikkelsen et al. · Clinical Pharmacology & Therapeutics · 2009 · 401 citations · Full text

, , +17

1–5 of 253